This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sklar, J. Articles by Nies, A. S. Search for Related Content PubMed PubMed Citation Articles by Sklar, J. Articles by Nies, A. S.

Circulation, Vol 65, 894-899, Copyright © 1982 by American Heart Association

ARTICLES

The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men

J Sklar, GD Johnston, P Overlie, JG Gerber, HL Brammell, J Gal and AS Nies

We compared the effects of a cardioselective beta-adrenergic blocking drug, metoprolol, with a nonselective beta-adrenergic blocker, propranolol, on the response of 10 normal men to dynamic treadmill exercise. The volunteers underwent a standard graded exercise test to exhaustion while receiving placebo; propranolol, 40 mg every 6 hours; propranolol, 80 mg every 6 hours; metoprolol, 50 mg every 6 hours; or metoprolol, 100 mg every 6 hours. The drugs were given in a double- blind fashion for 48 hours before exercise. Five days were allowed between successive drug administrations and the order of drug administration was randomized. Heart rate, arterial pressure, oxygen consumption, minute ventilation and CO2 production were monitored. Plasma drug concentrations were measured at the time of exercise. Judged by plasma levels, propranolol was about three times more potent than metoprolol in attenuating heart rate. Both drugs produced a wide variation in plasma levels after a given oral dose, and both drugs attenuated the systolic blood pressure response to exercise. Neither drug affected diastolic blood pressure or maximum oxygen consumption, maximum minute ventilation or the anaerobic threshold. We conclude that there is no evidence that the cardioselective drug metoprolol is superior to propranolol in terms of the ability to perform or respond to short-term maximal exercise. In addition, the fact that maximal oxygen consumption and the anaerobic threshold were unaffected implies that fatigue during exercise while on beta-adrenergic blocking drugs is not due to an effect of these drugs in limiting blood flow to the exercising extremities.

This article has been cited by other articles:

				M. N. Hawkins, Q. Barnes, S. Purkayastha, W. Eubank, S. Ogoh, and P. B. Raven The effects of aerobic fitness and {beta}1-adrenergic receptor blockade on cardiac work during dynamic exercise J Appl Physiol, February 1, 2009; 106(2): 486 - 493. [Abstract] [Full Text] [PDF]

				D. K. Rohrer, E. H. Schauble, K. H. Desai, B. K. Kobilka, and D. Bernstein Alterations in dynamic heart rate control in the beta 1-adrenergic receptor knockout mouse Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1184 - H1193. [Abstract] [Full Text] [PDF]

				F. M. Gengo, S. C. Fagan, A. de Padova, J. K. Miller, and P. R. Kinkel The Effect of {beta}-Blockers on Mental Performance on Older Hypertensive Patients Arch Intern Med, April 1, 1988; 148(4): 779 - 784. [Abstract] [PDF]

				F. M. Gengo, L. Huntoon, and W. B. McHugh Lipid-Soluble and Water-Soluble {beta}-Blockers: Comparison of the Central Nervous System Depressant Effect Arch Intern Med, January 1, 1987; 147(1): 39 - 43. [Abstract] [PDF]